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Abstract
The cytoplasmic tail of Notch ligands drives endocytosis, mediates association with proteins
implicated in the organization of cell-cell junctions and, through regulated intra-membrane
proteolysis, is released from the membrane as a signaling fragment. We survey these findings and
discuss the role of Notch ligands intracellular region in bidirectional signaling and possibly in signal
modulation in mammals.
Reviewers: This article was reviewed by Frank Eisenhaber, L Aravind, and Eugene V. Koonin.
Background
Notch-mediated signal transduction controls cell fate and
is a key process in tissue patterning and morphogenesis
[1]. Both receptors and ligands are membrane-bound pro-
teins, the first ones being non-covalent, membrane-span-
ning heterodimers, the latters single pass, type I
membrane proteins [1]. In response to ligand binding, the
membrane-spanning subunit of the receptor (NTM) is
cleaved by an extracellular ADAM-type (A Disintegrin And
Metalloprotease) proteinase. This cleavage facilitates a
further cleavage of NTM, within the trans-membrane
region, carried out by the presenilin/γ-secretase protease
and releases the intracellular domain (ICN) from the
membrane [2]. This series of controlled proteolytic events
is referred to as "regulated intra-membrane proteolysis" or
RIP. Once translocated into the nucleus, the ICN interacts
with nuclear factors that activate transcription, the main
target being a transcription factor (CSL) called CBF1/RBP
in mammals, Suppressor of Hairless in Drosophila, and
LAG-1 in C. elegans.
The core mechanism of the Notch pathway can be thus
viewed as the release of a transcriptional regulator from
the membrane, triggered by ligand/receptor interactions
and controlled at various levels. The established role of
Notch signaling in angiogenesis [3], in T cell development
[4], in the maintenance of stem cells [5], in genetic disor-
ders [6] as well as in cancer [7,8] has been extensively
reviewed. The Notch pathway has been identified as a new
potential target for cancer therapy [9,10] and might also
be involved in cognitive disorders [11]. Other aspects of
Notch signaling, such as its regulation by endocytic proc-
esses [12] and receptor glycosylation [13], and the cross-
talk between Notch and other signaling pathways [14,15]
have also been reviewed.
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Here, we focus on a relatively recent and potentially novel
aspect of Notch signaling in mammals: the role of the
intracellular region of the membrane-spanning ligands in
the interaction with membrane-associated proteins, in the
endocytic processes that control receptor/ligand interac-
tions, and as membrane-tethered signaling fragments.
Does the tail make the difference?
All Notch ligands share a similar architecture (Figure 1): a
poorly characterized N-terminal region required for recep-
tor binding, a Delta/Serrate/Lag-2 (DSL) domain, a varia-
ble number of EGF-like repeats, a trans-membrane
segment, and a relatively short (~100–150 amino acids)
cytoplasmic tail [16]. Traditionally, ligands are classified
in two distinct families: homologues of Drosophila Delta
protein (Delta-1, -3, and -4 in mammals) and homo-
logues of Drosophila  Serrate (Jagged-1 and -2 in mam-
mals). Jagged ligands have an additional, cysteine-rich
region proximal to the trans-membrane segment. Within
the same ligand type, the intracellular region of Notch lig-
ands is well conserved through evolution, while different
ligand types show quite distinct cytoplasmic tails. From
multiple sequence alignments, the presence of relatively
well distinct groups can be identified (Figure 2 and Figures
3, 4, 5, 6, 7). These groups include orthologues of human
Jagged-1 (J1), of human Jagged-2 (J2), of human Delta-1
(D1) and Delta-4 (D4). Two additional, more heteroge-
nous groups include orthologues of human Delta-3 (D3)
and other more distantly related ligands. Groups J1 and J2
make a superfamily, as well as groups D1 and D4. Group
D3 sits somewhat apart, and cannot be reliably assigned
to any superfamily. Indeed, some of the sequences cannot
be assigned to a definite group with high enough confi-
dence. While the intracellular region of Drosophila Serrate
does appear to be related to the J1 and J2 groups, Dro-
sophila Delta is only distantly related to the D1 and D4
groups. In a similar way, C. elegans LAG2 can be assigned
to the D3 group with low confidence and APX1 is only
distantly related to the D1 and D4 groups. It can be
remarked that sequence conservation is not limited to the
C-terminal, PDZ-interacting motif, but extends well
beyond the C-terminal residues. Predictions supported by
preliminary experimental results [17] point towards a
mainly disordered nature for Notch ligands cytoplasmic
tail (Figure 8). On the other hand, sequence conservation
within ligand types suggests that precise sequence charac-
teristics might be required for specific patterns of post-
translational modifications to take place and for specific
protein-protein interactions to occur.
Predictions of phosphorylation, O-glycosylation with β-
N-acetylglucosamine, and ubiquitination sites, as well as
protein-protein interaction motifs, are shown for the cyto-
plasmic tail of human Notch ligands in Figure 9. It can be
speculated that specific protein-protein interaction motifs
on different ligands can specify different interaction
patchworks. For example, PDZ-binding motifs are pre-
dicted for Jagged-1, Delta1, and Delta-4, but not for Jag-
ged-2 and Delta-3; SH2-binding motifs are predicted for
Jagged-1, Delta-1, and Delta-3, but not for Jagged-2 and
Delta-4. Different phosphorylation patterns may also
drive different protein interaction networks. The main
experimental findings are summarized hereafter and
shown in Figure 10.
The cytoplasmic tail couples Notch ligands to PDZ-
containing proteins
Independent on the interaction with receptors, the cyto-
plasmic tail of Notch ligands couples the Notch signal
transduction machinery to PDZ containing, membrane
associated proteins that play a role in the organization of
cell-cell junctions. Jagged-1 has been shown to interact
with the unique PDZ domain of the ras-binding protein
afadin (AF6) in a PDZ-dependent manner [18,19]. Dlg1,
the human homolog of the Drosophila Discs Large protein,
was identified through peptide-affinity chromatography
as a binding partner for Delta-1 and -4 [20]. It was shown
that Delta-1/4 can recruit Dlg1 at cell-cell junctions, tight-
ing cell contacts and reducing cell motility [20]. The inter-
action is PDZ-dependent, although it was not determined
Domain architecture of Notch ligands Figure 1
Domain architecture of Notch ligands. Typical domain organization of Notch ligands: MNLL, N-terminal domain; DSL, Delta/
Serrate Ligand domain; EGF, Epidermal Growth Factor repeat; VWC, von Willebrand Factor type C domain. The transmem-
brane segment is shown as a blue bar. The number and type of EGF repeats can vary.Biology Direct 2007, 2:19 http://www.biology-direct.com/content/2/1/19
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Sequence analysis Figure 2
Sequence analysis. The intracellular regions of Notch ligands from different organisms were aligned automatically using Clus-
talW (score matrix: Gonnet, penalty for gap opening, 10; penalty for gap closing, 1; penalty for gap extension, 0.2; penalty for 
gap separation, 8). The cladogram was generated using the neighbor joining algorithm and drawn using Mega [41]. Confidence 
values for grouping in the tree were obtained by bootstrapping (N = 1000) and normalized to 100. Identified groups are 
labelled as J1, J2, D1, D4, D3, and colored accordingly. The branching points between J1 and J2 and between D1 and D4 groups 
are also labeled. Ligands sharing the same architecture in the extracellular regions are enclosed in brackets. Similar results 
were obtained using T-Coffee [42] and MUSCLE [43].Biology Direct 2007, 2:19 http://www.biology-direct.com/content/2/1/19
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which of the three PDZ domains in Dlg1 mediates this
interaction. In similar studies, the interaction between
Delta-1 and members of the MAGI family (Membrane
Associated Guanylate Kinases with Inverted domain
arrangement) has been reported [21,22]. The interaction
specifically occurs between the C-terminus of the Delta
proteins and the fourth PDZ domain of MAGIs. As there
are over 300 human proteins containing at least one PDZ
domain [16,23], it is not clear yet whether specific recog-
nition relies on subtle differences in the PDZ domains
[24], on a binding region larger then the canonical, C-ter-
minal PDZ-binding tetrapeptide [25], or both. It can be
remarked that the C-terminus of Delta-3 and Jagged-2 do
not contain any PDZ binding motif.
Ubiquitination of the intracellular region drives 
endocytosis
Extensive studies on Drosophila and other model systems
[12] have shown that the cytoplasmic tail of Notch lig-
ands undergoes ubiquitination, which in turn drives
endocytosis. As endocytosis removes the ligand from the
cell surface subtracting it from the interaction with the
receptor, different, non-mutually exclusive models were
proposed to solve this apparent contraddiction. Ligand
endocytosis would create a mechanical "pulling force" on
the receptor. This force would either promote a conforma-
tional change that exposes the juxtmembrane region of
the receptor to proteolytic cleavage [26], thus triggering
the second cleavage of the ICN, or physically dissociates
Sequence alignment J1 Figure 3
Sequence alignment, group J1. Sequences were  aligned using ClustalW and colored using CINEMA. Acidic residues (D, E) in 
red; basic (K, R) in blue; histidines (H) in light blue; aliphatic (A, V, L, I, M) in white; small hydrophobic (G, P) in orange; aro-
matic (F, Y, W) in magenta; hydroxyl-containing (S, T) in dark green; amide containing (N, Q) in light green; cysteines (C) in yel-
low.Biology Direct 2007, 2:19 http://www.biology-direct.com/content/2/1/19
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Sequence alignment J2 Figure 4
Sequence alignment, group J2. Sequences were  aligned using ClustalW and colored using CINEMA. Acidic residues (D, E) in 
red; basic (K, R) in blue; histidines (H) in light blue; aliphatic (A, V, L, I, M) in white; small hydrophobic (G, P) in orange; aro-
matic (F, Y, W) in magenta; hydroxyl-containing (S, T) in dark green; amide containing (N, Q) in light green; cysteines (C) in yel-
low.Biology Direct 2007, 2:19 http://www.biology-direct.com/content/2/1/19
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Sequence alignment D1 Figure 5
Sequence alignment, group D1. Sequences were aligned using ClustalW and colored using CINEMA. Acidic residues (D, E) in 
red; basic (K, R) in blue; histidines (H) in light blue; aliphatic (A, V, L, I, M) in white; small hydrophobic (G, P) in orange; aro-
matic (F, Y, W) in magenta; hydroxyl-containing (S, T) in dark green; amide containing (N, Q) in light green; cysteines (C) in yel-
low.Biology Direct 2007, 2:19 http://www.biology-direct.com/content/2/1/19
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the Notch heterodimer directly promoting activation [27].
It has also been proposed that ligands would be "acti-
vated" in the acidic endosomal compartments, before
being recycled to the cell surface. Alternatively, ligands
would cluster in multivesicular bodies before being
released to the extracellular space as exosomes. Four E3
ubiquitin ligases have been identified in mammals, Mind
Bomb-1 (Mib1), Mind Bomb-2 (Mib2, Skeletrophin),
Neuralized-1 (Neur1) and -2 (Neur2). Mib and Neural-
ized proteins display different domain architectures,
which might be related to their interaction with different
targets: Mibs contain a HERC2/ZZ Zinc finger/HERC2
block followed by a series of ankirin repeats and two or
three RING finger domains, Neur1 contains two Neural-
ized domains and a single RING finger, Neur2 a Neural-
ized domain and a Socs box. Mouse Mib1 was shown by
co-immunoprecipitation to bind all Notch ligands in
HEK293A cells and to promote their endocytosis in COS7
cells [28]. Knock-out [28] or mutation [29] of the Mib1
gene lead to developmental defects and death in mouse
embryos. Mouse Mib2, although functionally related to
Mib1, has a different expression pattern [30] and bind
and ubiquitinates specifically Jagged-2, and not the other
Notch ligands [31]. Knock-out of the Neur1 gene lead to
Sequence alignment D4 Figure 6
Sequence alignment, group D4. Sequences were aligned using ClustalW and colored using CINEMA. Acidic residues (D, E) in 
red; basic (K, R) in blue; histidines (H) in light blue; aliphatic (A, V, L, I, M) in white; small hydrophobic (G, P) in orange; aro-
matic (F, Y, W) in magenta; hydroxyl-containing (S, T) in dark green; amide containing (N, Q) in light green; cysteines (C) in yel-
low.Biology Direct 2007, 2:19 http://www.biology-direct.com/content/2/1/19
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viable and morphologically normal mice, yet displaying
several defects [32,33]. Finally, Neur2 was found to bind
and ubiquitinate Delta-1 in HEK293A cells [34]. How-
ever, Neur2 and Mib1 displayed different subcellular
localization, suggesting different and complementary
roles for these two E3 ligases. Whereas in model organ-
isms the only apparent function of the intracellular region
is to carry lysine residues that can be ubiquitinylated to
trigger endocytosis [35,36], it is not clear yet whether in
mammals the differences in the cytoplasmic tails are
underlying more specific mechanisms to control the
endocytic pathways.
Notch ligands undergo regulated intra-membrane 
proteolysis
It has been recently shown that in mammals Notch lig-
ands undergo a proteolytic processing similar to that
reported for Drosophila  Delta and for Notch receptors.
Murine Delta-1 was shown to be sequentially processed
by an ADAM proteinase and by γ-secretase, the extracellu-
lar cleavage site being localized 10 residues N-terminal to
the trans-membrane segment [37]. Also rat Jagged-1 [38]
and human Jagged-2 [39] were shown to undergo the
same type of proteolytic processing. ADAM 17 and ADAM
10 were identified as the proteinases involved in the ecto-
domain shedding of Jagged and Delta, respectively. The
intra-membrane cleavage site has not been determined
yet. In Jagged-1, it has been proposed to be placed at the
first Val residue close to the cytoplasmic region [38]. The
intracellular region of these ligands, after release from the
cell membrane, was localized in the cytoplasm as well as
in the nucleus [37-39].
The intracellular region as a membrane-tethered 
transcriptional regulator?
The regulated intra-membrane proteolysis, followed by
the release from the membrane and the localization in the
nucleus, suggests a possible role of the intracellular region
in transcriptional regulation. In cotransfection studies, the
intracellular region of Jagged-1 was able to promote tran-
scription of a reporter gene in COS, CHO, and HEK cells
specifically through the AP1 (Activator Protein 1, p39 jun)
enhancer element [38]. Activation by Jagged-1 is at odds
with AP1 repression carried out by the intracellular
domain of Notch. There is no experimental evidence,
however, that the intracellular region of Notch ligands can
bind DNA directly and, indeed, they do not contain any
recognizable DNA binding motif. More probably, they
function in combination with transcriptional complexes
or specific transcription factors. Evidence in this direction
is given by the interaction observed between the mouse
Delta-1 intracellular region and specific Smad transcrip-
tion factors (Smad-2, -3, and -4) involved in TGF-β/
activin signaling [40]. Interestingly, it has been noticed
Sequence alignment D3, mammalian sequences only Figure 7
Sequence alignment, group D3. Sequences (from mammals only) were aligned using ClustalW and colored using CINEMA. 
Acidic residues (D, E) in red; basic (K, R) in blue; histidines (H) in light blue; aliphatic (A, V, L, I, M) in white; small hydrophobic 
(G, P) in orange; aromatic (F, Y, W) in magenta; hydroxyl-containing (S, T) in dark green; amide containing (N, Q) in light 
green; cysteines (C) in yellow.Biology Direct 2007, 2:19 http://www.biology-direct.com/content/2/1/19
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that one of the PDZ-containing proteins that binds Delta-
1 also interacts with Activin Type 2 receptors and Smad-3
[40].
In conclusion, there is compelling evidence that bidirec-
tional signaling is mediated by the intracellular region of
Notch ligands. While the core mechanism of signal trans-
duction mediated by Notch receptors and their ligands
has been maintained through evolution, the differentia-
tion of ligands in higher eukaryots and the unique
sequence features of their intracellular region is likely to
be related to specific post-translational modifications and
protein-protein interaction motifs that link the Notch sig-
naling pathway to other signaling networks. The identifi-
cation of new binding partners – at the cell membrane, in
the cytoplasm and in the nucleus – as well as the charac-
terization of the post-translational modification patterns
will bring new insights into this aspect of the Notch net-
work.
Reviewers comments
Reviewer's report 1
Frank Eisenhaber, Bioinformatics Group, Institute of
Molecular Pathology, Vienna, Austria
The authors present a review on the functional signifi-
cance and the sequence pattern-function correlations
within the intracellular part of Notch ligands. Whereas
this review is of considerable interest, the authors might
consider the following points for making their MS even
more informative:
1) It would be good for the reader to see diagrams of the
sequence architecture of representatives of the several
Notch ligand classes as a figure.
2) There are many methods to evaluate and to predict
intrinsically unfolded regions. The authors might wish to
show to which extent segments of the notch ligand
sequences do represent such reasons.
3) There are no Ying-Yang sites (except you define them,
see page 4 bottom); better, speak about O-glycosylation
sites.
4) The work would win from a more distinct summary
with the conclusions explicitely listed.
Authors' response
1) A diagram showing the typical domain architecture of
Notch ligands has been added as Figure 1.
2) Intrinsic disorder in the cytoplasmic region of Notch
ligands has been calculated using two different methods.
The first is based on the plot of the mean net charge v. the
mean hydrophobicity, as described by Uversky et al. in ref.
[44]; the second is based on DisEMBL (ref. [45]). The two
methods are somewhat complementary, in that the first is
based only on the amino acid composition and the phys-
ical properties of amino acid types, the second on the sec-
ondary and tertiary structure determinants in the
sequence. Results have been summarized in a new figure
(Figure 4a–b).
Intrinsic disorder Figure 8
Intrinsic disorder. Disorder in the extracellular (black circles/
bars) and intracellular (red circles/bars) regions of Notch lig-
ands are shown as (a) a plot of the mean net charge v. the 
mean hydrophobicity [44] and (b) as the percentage of disor-
dered residues calculated by DisEMBL using the "hot loops" 
definition [45]. In (a), the border between folded and natively 
unfolded proteins is drawn as a line.Biology Direct 2007, 2:19 http://www.biology-direct.com/content/2/1/19
Page 10 of 13
(page number not for citation purposes)
Functional analysis Figure 9
Functional analysis. Potential binding sites and post-translational modifications predicted by ELM [46, 47], NetPhos [46], and O-
glycosylation [48] for the cytoplasmic tail of human Notch ligands. Prediction of ubiquitination sites is based on the preference 
for acidic residues adjacent to the target lysine [49]. 14-3-3, 14-3-3 proteins interacting motif (Ser/Thr phosphorylation 
required); Cyc, cyclin binding site; FHA, forkhead-associated domain interaction motif 1 (Thr phosphorylation required); PDZ, 
class I, II, or III PDZ binding motif; SH2, Src Homology 2 (SH2) domains interaction motif (tyrosine phosphorylation required; 
subtypes include GRB2, SH-PTP2, SRC, STAT3, STAT5, STAT6); SH3, SH3 domains binding motif (subtypes include class I, 
class II, and other non-canonical motifs); TRAF2, tumor necrosis factor receptor associated protein binding motif; Ub, ubiquiti-
nation site; WW, WW domain binding motif (subtypes include Group I (PPXY), Group II (PPLP), Group III, and Group IV, 
which requires Ser/Thr phosphorylation). Tyrosine-based sorting signals responsible for the interaction with the μ subunit of 
the AP (Adaptor Protein) complex are shown as doughnuts. Potential phosphorylation sites are in red; kinases are abbreviated 
as follows: CDK, Ser/Thr cyclin dependent kinase; CK1, casein kinase 1; CK2, casein kinase 2; GSK3, glycogen synthase kinase 
3; PKA, protein kinase A; PKB, protein kinase B; PDK, Proline-Directed Kinase; PLK, Polo-like-kinase. ITIM, immunoreceptor 
tyrosine-based inhibitory motif (tyrosine phosphorylation required); ITSM, immunoreceptor tyrosine-based switch motif (tyro-
sine phosphorylation required). Sites that are candidates for O-glycosylation with β-N-acetylglucosamine are shown as grey 
diamonds; sites that are predicted to be both glycosylated and phosphorylated are shown as black diamonds.Biology Direct 2007, 2:19 http://www.biology-direct.com/content/2/1/19
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3) All potential O-glycosylation sites have now been
included, independently on phosphorylation, and added
in Figure 5, which has been revised accordingly.
4) Biology Direct allows only for a very short Abstract/
Summary in "review" papers. Instead, we tried to list the
main points in the "conclusion" paragraph.
Reviewer's report 2
L Aravind, Computational Biology Branch, NCBI, NLM,
NIH, Bethesda, USA
The paper reviews the role of the Notch family ligands in
signal transduction. While the role of the notch intracellu-
lar regions has been intensely investigated, the role of the
intracellular portions of the corresponding ligands is less
understood. In this paper Pintar et al review the current
understanding of the signaling functions of the cytoplas-
mic tails of the DSL ligands.
The key points I have are:
1) Figure 3 shows potential modification and binding
sites on the human notch ligand. Given that alignments
were made for the various ligand families it will be useful
to prioritize the predicted binding and PTM sites based on
their conservation within a ligand family. This might indi-
cate their greater generality in terms of a conserved signal-
ing role.
2) "The intracellular region as a membrane-tethered tran-
scription factor?": pg 7 of the PDF file. Is the evidence
really favoring the intracellular tail as a TF itself? It is better
to state that the intracellular region of the DSL ligands
might function in conjunction with transcription factors.
The authors might want to point out that the tail itself
does not seem to have any recognizable DNA binding
domains and might instead function in conjunction with
a known transcription factor like SMAD.
Minor
Stylistic issue: As per BMC specifications I believe figure
2A, 2B etc need to be split up into separate figures.
"Activation by Jagged-1 is at odd with AP1 repression..."
Activation by Jagged-1 is at *odds* with AP1 repression
Page 6: The Ub E3 ligases: you might want to specify that
they have RING finger domains as the active E3 compo-
nent. It would also be nice if you mentioned the interest-
ing complex domain architectures of the Mind bomb E3s
in the text (or may be show it in the fig. 4)
Authors' response
1) This is an interesting observation. There are actually
post-translational modifications (PTM)/bindinf motifs
that are consistently predicted for all species, like the PDZ
binding motifs in Jagged-1 and DLL1/DLL4, and others
that are less conserved. Totally conserved motifs are likely
to be strictly required for fundamental processes, whereas
less conserved PTMs/binding motifs may play a role in
some sort of fine tuning of the developmental processes
governed by Notch signaling, and might be different in
different species. From a practical point of view, it is diffi-
cult to summarize all the predictions for all species, and
this is why we restricted the results to human ligands. For
a reader interested in a particular PTM/binding motif, it is
probably easier to jump from Figure 9 to Figures 3, 4, 5, 6,
7 to check if that feature is conserved, to what extent, and
in which species.
2) We agree with the reviewer's comment. The title of the
paragraph has been reformulated and we specified in the
text that the intracellular region of Notch ligands may play
a role in transcriptional regulation, but in an indirect
manner.
Figure 2 has been splitted in separate figures.
The spelling mistake has been corrected.
Interaction network Figure 10
Interaction network. Summary of experimentally verified 
interactions for the intracellular region of human or rodent 
Notch ligands. Proteases are shown as octagons, PDZ-con-
taining proteins as hexagons, E3-ubiquitin ligases as dia-
monds, transcription factors as smoothed squares; the AP1 
enhancer element is shown as a square; phosphorylation of 
Delta-1 by an unknown kinase (Kin) is also shown. Interac-
tions expected by similarity as shown as dotted lines. The 
graph was drawn using Cytoscape [50].Biology Direct 2007, 2:19 http://www.biology-direct.com/content/2/1/19
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E3 ubiquitin ligases: we added a short paragraph men-
tioning the different domain architecture of these E3
ubiquitin ligases.
Reviewer's report 3
Eugene V. Koonin, NCBI, NLM, NIH, Bethesda, USA
This is a very concise, to the point review emphasizing the
diverse functions of the cytoplasmic tails of Notch lig-
ands. The ever-growing evidence of the importance of RIP
for diverse processes and the complexity of the system are
remarkable.
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